CIK: 1769333 - Address: 6000 Shoreline Court, Suite 300, South San Francisco, CA 94080
46 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/8/22 17:18
12/6/22
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS-2827.030-1-266D
11/15/22 17:02
11/11/22
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d029.3400068D
11/15/22 17:02
11/11/22
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d014.3400068D
11/8/22 17:44
11/4/22
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS-2625.000-1-168D
3/9/22 20:46
3/4/22
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.ad-57925.120-23-2761D
3/9/22 20:46
3/4/22
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.ad265.9804861D
3/7/22 16:34
3/4/22
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-57825.120-23-2761D
3/7/22 16:34
3/4/22
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d265.9804861D
12/8/21 16:42
12/6/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.dm-57937.710-15-2448D
12/8/21 16:42
12/6/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.dm25717.970144248D
9/9/21 17:07
9/7/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.dm-68050.550-13-2150D
9/9/21 17:07
9/7/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d21016.770133350D
6/25/21 16:12
6/23/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-17439.750-4-852D
6/25/21 16:12
6/23/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d10824.6904952D
6/8/21 16:38
6/4/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-31534.630-9-1552D
6/8/21 16:38
6/4/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d10212.52081952D
3/8/21 17:33
3/4/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-2,56749.360-52-4954D
3/8/21 17:33
3/4/21
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d58218.8003113654D
12/4/20 19:42
12/4/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-79756.880-14-1578D
12/4/20 19:42
12/4/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d15011.150132178D
10/7/20 17:06
10/6/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-8835.210-3-379D
10/7/20 17:06
10/6/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d5120.2103379D
9/8/20 17:54
9/4/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-21931.100-7-879D
9/8/20 17:54
9/4/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d507.6606979D
8/4/20 20:05
7/31/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-70735.330-20-2080D
8/4/20 20:05
7/31/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d40420.210203380D
7/14/20 20:29
7/13/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-49629.660-17-1780D
7/14/20 20:29
7/13/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d21813.050172680D
6/4/20 16:16
6/3/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-28326.220-11-1280D
6/4/20 16:16
6/3/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d777.540101580D
3/4/20 17:49
3/3/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-83525.390-33-2981D
3/4/20 17:49
3/3/20
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d1077.130152381D
12/9/19 16:15
12/5/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d47014.3403323347D
12/9/19 16:15
12/5/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-96429.390-33-4147D
12/4/19 16:22
12/3/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-40626.470-15-2547D
12/4/19 16:22
12/3/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d1077.120154747D
12/2/19 16:13
11/27/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-10929.360-4-747D
12/2/19 16:13
11/27/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d5314.3404847D
9/5/19 17:23
9/3/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.dm-38825.320-15-2447D
9/5/19 17:23
9/3/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d1077.130154647D
8/14/19 16:15
8/12/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.dm-83525.390-33-4148D
8/14/19 16:15
8/12/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.dm2818.6103321148D
3/5/19 16:48
3/4/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-35720.240-18-2749D
3/5/19 16:48
3/4/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d1055.980185749D
3/4/19 19:05
2/28/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScM.d2997.9903733349D
3/4/19 19:05
2/28/19
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesKennedy Giulia CCAOChief ScS.d-76420.450-37-4349D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact